These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 22596155)

  • 21. Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia.
    Wang K; Ahmad S; Cai M; Rennie J; Fujisawa T; Crispi F; Baily J; Miller MR; Cudmore M; Hadoke PW; Wang R; Gratacós E; Buhimschi IA; Buhimschi CS; Ahmed A
    Circulation; 2013 Jun; 127(25):2514-22. PubMed ID: 23704251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early postpartum changes in circulating pro- and anti-angiogenic factors in early-onset and late-onset pre-eclampsia.
    Wikström AK; Larsson A; Eriksson UJ; Nash P; Olovsson M
    Acta Obstet Gynecol Scand; 2008; 87(2):146-53. PubMed ID: 18231881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripartum cardiomyopathy.
    Rodríguez-González MA; Medina-Ruíz A
    P R Health Sci J; 2006 Sep; 25(3):267-71. PubMed ID: 17203798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers and Their Relation to Cardiac Function Late After Peripartum Cardiomyopathy.
    Ersbøll AS; Goetze JP; Johansen M; Hauge MG; Sliwa K; Vejlstrup N; Gustafsson F; Damm P
    J Card Fail; 2021 Feb; 27(2):168-175. PubMed ID: 33422687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripartum cardiomyopathy: An epidemiologic study of early and late presentations.
    Masoomi R; Shah Z; Arany Z; Gupta K
    Pregnancy Hypertens; 2018 Jul; 13():273-278. PubMed ID: 30177065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aetiology and risk factors of peripartum cardiomyopathy: a systematic review.
    Ntusi NB; Mayosi BM
    Int J Cardiol; 2009 Jan; 131(2):168-79. PubMed ID: 18722678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling.
    Cindrova-Davies T; Sanders DA; Burton GJ; Charnock-Jones DS
    Cardiovasc Res; 2011 Feb; 89(3):671-9. PubMed ID: 21139021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripartum cardiomyopathy: a challenge for cardiologist.
    Aursulesei V
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):358-67. PubMed ID: 24340517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practical management of peripartum cardiomyopathy.
    Kim MJ; Shin MS
    Korean J Intern Med; 2017 May; 32(3):393-403. PubMed ID: 28407464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
    Pfeffer TJ; Mueller JH; Haebel L; Erschow S; Yalman KC; Talbot SR; Koenig T; Berliner D; Zwadlo C; Scherr M; Hilfiker-Kleiner D; Bauersachs J; Ricke-Hoch M
    ESC Heart Fail; 2023 Feb; 10(1):465-477. PubMed ID: 36300679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripartum Cardiomyopathy.
    Douglass EJ; Blauwet LA
    Cardiol Clin; 2021 Feb; 39(1):119-142. PubMed ID: 33222808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripartum cardiomyopathy.
    Ro A; Frishman WH
    Cardiol Rev; 2006; 14(1):35-42. PubMed ID: 16371764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripartum Cardiomyopathy.
    Arany Z; Elkayam U
    Circulation; 2016 Apr; 133(14):1397-409. PubMed ID: 27045128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiology and risk factors of peripartum cardiomyopathy.
    Hoes MF; Arany Z; Bauersachs J; Hilfiker-Kleiner D; Petrie MC; Sliwa K; van der Meer P
    Nat Rev Cardiol; 2022 Aug; 19(8):555-565. PubMed ID: 35017720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Connecting the Dots: Exploring the Interplay Between Preeclampsia and Peripartum Cardiomyopathy.
    Gumilar KE; Rauf KBA; Akbar MIA; Imanadha NC; Atmojo S; Putri AY; Dachlan EG; Dekker G
    J Pregnancy; 2024; 2024():7713590. PubMed ID: 38957710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subsequent reproductive outcome among women with peripartum cardiomyopathy: a nationwide study.
    Guldbrandt Hauge M; Johansen M; Vejlstrup N; Gustafsson F; Damm P; Ersbøll AS
    BJOG; 2018 Jul; 125(8):1018-1025. PubMed ID: 29211333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolactin fragmentation by trophoblastic matrix metalloproteinases as a possible contributor to peripartum cardiomyopathy and pre-eclampsia.
    Reuwer AQ; Reuwer PJ; van der Post JA; Cramer MJ; Kastelein JJ; Twickler MT
    Med Hypotheses; 2010 Feb; 74(2):348-52. PubMed ID: 19748190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis.
    Bello N; Rendon ISH; Arany Z
    J Am Coll Cardiol; 2013 Oct; 62(18):1715-1723. PubMed ID: 24013055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β1-Adrenoceptor antibodies induce PPCM
    Zhang Y; Liu J; Shi L; Chen M; Liu J
    Scand Cardiovasc J; 2021 Jun; 55(3):160-167. PubMed ID: 33412941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenesis in gestational vascular complications.
    Yagel S
    Thromb Res; 2011 Feb; 127 Suppl 3():S64-6. PubMed ID: 21262445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.